Invention Grant
- Patent Title: Contrast dose reduction for medical imaging using deep learning
-
Application No.: US16155581Application Date: 2018-10-09
-
Publication No.: US10997716B2Publication Date: 2021-05-04
- Inventor: Greg Zaharchuk , Enhao Gong , John M. Pauly
- Applicant: The Board of Trustees of the Leland Stanford Junior University
- Applicant Address: US CA Stanford
- Assignee: The Board of Trustees of the Leland Stanford Junior University
- Current Assignee: The Board of Trustees of the Leland Stanford Junior University
- Current Assignee Address: US CA Stanford
- Agency: Lumen Patent Firm
- Main IPC: G06T7/00
- IPC: G06T7/00 ; G06T3/60 ; G06N3/08 ; G06T5/00 ; G16H30/40 ; G06T7/50 ; G16H50/20

Abstract:
A method for diagnostic imaging with reduced contrast agent dose uses a deep learning network (DLN) [114] that has been trained using zero-contrast [100] and low-contrast [102] images as input to the DLN and full-contrast images [104] as reference ground truth images. Prior to training, the images are pre-processed [106, 110, 118] to co-register and normalize them. The trained DLN [114] is then used to predict a synthesized full-dose contrast agent image [116] from acquired zero-dose and low-dose images.
Public/Granted literature
- US20190108634A1 Contrast Dose Reduction for Medical Imaging Using Deep Learning Public/Granted day:2019-04-11
Information query